Abstract
This 760-page report presents a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 100 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products.
The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains: 760 pages and 31 tables.
Table of Contents
1. Worldwide Business Environment
2. Worldwide Market Structure
3. Worldwide Market Size and Growth
4. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako
List of Tables
- Table 1: Laboratories Performing Infectious Disease Tests by Country
- Table 2: Infectious Disease Test Volume Forecasts by Country
- Table 3: Infectious Disease Diagnostics Market Forecasts by Country
Analysis of Emerging Infectious Disease Tests and Strategic Profiles of Leading Suppliers published by Venture Planning Group in September 18, 2012. This report price starts from US $ 3500.
